Testosterone 00591-2926-30
- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Gel
- Route
- Transdermal
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- February 12, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA204570
Active Ingredients
| Ingredient | Strength |
|---|---|
| Testosterone | 16.2 mg/g |
Drug Class
Androgen [EPC]Androgen Receptor Agonists [MoA]Androgen [EPC]
Selected Package
00591-2926-30Selected30 PACKET in 1 CARTON (0591-2926-30) / 2.5 g in 1 PACKET (0591-2926-25)